CGAU
Centerra Gold Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $6.25 | $17 | +173% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $6.74 | $17 | +153% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $6.74 | $17 | +153% |
| D.E. Shaw | Q4 2024(8Q snapshot) | 6Q | $5.74 | $17 | +197% |
| AQR Capital Management | Q1 2026(8Q snapshot) | 1Q | $18 | $17 | -7% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | Q2 2026 | → $17 | +154% |
| Point72 Asset Management | Q4 2025 | Q2 2026 | → $17 | +43% |
| Bridgewater Associates 2× in & out | Q2 2025 | Q1 2026 | → $19 | +194% |
Fundamentals
XBRL · Centerra Gold Inc.Not enough XBRL history to plot. Centerra Gold Inc.hasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Centerra Gold Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KFORM 6-KMay 13, 2026
- 6-KFORM 6-KMay 5, 2026
- 6-KInterim disclosure (foreign)Apr 29, 2026
- 6-KFORM 6-KApr 29, 2026
- 6-KFORM 6-KApr 29, 2026
- 6-KFORM 6-KApr 8, 2026
- 6-KFORM 6-KApr 8, 2026
- 6-KFORM 6-KApr 2, 2026
- 6-KFORM 6-KMar 30, 2026
- 6-KFORM 6-KMar 23, 2026
- 6-KFORM 6-KMar 10, 2026
- 6-KFORM 6-KMar 5, 2026
- 6-KInterim disclosure (foreign)Feb 19, 2026
- 6-KFORM 6-KFeb 19, 2026
- 6-KFORM 6-KFeb 19, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| AQR Capital Management | Q1 2026 | open | $18 | $17 | -7% |
| Point72 Asset Management | Q4 2025 | Q2 2026 | $12 | $17 | +43% |
| Bridgewater Associates | Q2 2025 | Q1 2026 | $6.37 | $19 | +194% |
| D.E. Shaw | Q4 2024 | open | $5.74 | $17 | +197% |
| Citadel Advisors | Q3 2024 | Q2 2026 | $6.74 | $17 | +154% |
| Two Sigma Investments | Q3 2024 | open | $6.74 | $17 | +153% |
| Millennium Management | Q3 2024 | open | $6.74 | $17 | +153% |
| Renaissance Technologies | Q3 2024 | open | $6.25 | $17 | +173% |
| Bridgewater Associates | Q3 2021 | Q3 2022 | $6.46 | $4.64 | -28% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.